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Abstract
The present work compared the local injection of mononuclear cells to the spinal cord lateral funiculus with the alternative
approach of local delivery with fibrin sealant after ventral root avulsion (VRA) and reimplantation. For that, female adult
Lewis rats were divided into the following groups: avulsion only, reimplantation with fibrin sealant; root repair with fibrin
sealant associated with mononuclear cells; and repair with fibrin sealant and injected mononuclear cells. Cell therapy
resulted in greater survival of spinal motoneurons up to four weeks post-surgery, especially when mononuclear cells were
added to the fibrin glue. Injection of mononuclear cells to the lateral funiculus yield similar results to the reimplantation
alone. Additionally, mononuclear cells added to the fibrin glue increased neurotrophic factor gene transcript levels in the
spinal cord ventral horn. Regarding the motor recovery, evaluated by the functional peroneal index, as well as the paw print
pressure, cell treated rats performed equally well as compared to reimplanted only animals, and significantly better than the
avulsion only subjects. The results herein demonstrate that mononuclear cells therapy is neuroprotective by increasing
levels of brain derived neurotrophic factor (BDNF) and glial derived neurotrophic factor (GDNF). Moreover, the use of fibrin
sealant mononuclear cells delivery approach gave the best and more long lasting results.
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Introduction
In order to enhance the success of adult stem cell (SC)
translational medicine efforts, the source as well as the most
effective delivery method has to be considered. The bone marrow
contains endothelial progenitor cells and mononuclear cells (MC).
The MC fraction corresponds to the totality of hematopoietic and
mesenchymal stem cells. MC present clinical advantages over
other stem cells, based on the minimally invasive harvesting
procedures, which are fast and cost-effective. Also, the possibility
of autografting avoids the use of immunosuppressants, present low
oncogenic potential and does not raise ethical issues [1] as
compared to other SC. Moreover, MCs have similar potential
therapeutic outcome for nerve regeneration in comparison to
mesenchymal cells [2]. The peripheral nerve regeneration after
MC has been connected to the local production of neurotrophic
factors [1,3,4]. Relevantly, stem cell therapy may also present an
immunomodulatory effect, reducing pro-inflammatory events as
well as glial reaction following lesion.
Ventral root avulsion in rats has been used as a model for
brachial plexus lesion (BPL). BPL is frequently caused by
motorbike accidents in young adults as well as following
complicated child-birth delivery [5]. It causes paralysis in the
corresponding muscle groups and loss of sensory functions [6].
The degenerative impact on motoneurons is well characterized
and is potentiated by pulling out the ventral roots from the CNS/
PNS interface at the spinal cord surface [6]. Similarly to BPL,
VRA results in extensive loss of neurons in the first weeks after
injury [7,8].
Reimplantation of avulsed roots can rescue motoneurons from
degeneration, increasing the regenerative capacity of axonal
regrowth [9,10]. As a result, anatomical and functional reinner-
vation of denervated muscles can be obtained [11–13]. As seen in
a previous work [10], a snake venom derived fibrin sealant allowed
successful and stable ventral root implantation. Nevertheless,
additional therapeutic approaches need to be developed, since root
reimplantation alone, although neuroprotective, results in insuffi-
cient functional sensory-motor recovery [12,14–16].
In order to improve the outcome following VRA, regarding
neuronal survival, several attempts have been made to provide
neurotrophic molecules at the site of injury. In this regard, the
association of the root reimplantation with BDNF and CNTF
resulted in rescue of injured motoneurons after avulsion in rabbits
[17]. Therefore, the use of neurotrophic factors in combination
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with root reimplantation is a potential therapy to be used in
patients.
The use of recombinant neurotrophic factors, however, present
important drawbacks. One of them is the need of relatively large
amounts of the purified substance, to reach the target lesioned
area. Due to the short biological activity window of such
substances, there is also need of constant perfusion, what may
contribute to infection and further lesion of the affected spinal cord
area. Additionally, it is improbable that a single neurothrophic
molecule will be sufficient to provide the necessary conditions for
optimal regeneration.
Based on such facts, the advent of stem cell technology brought
new insights on cell therapy and local delivery of trophic
substances. To date, however, there is not sufficient data on the
delivery method to the nervous system, especially following VRA.
So far, it is known that mesenchymal stem cells synthesize and
possibly release BDNF and GDNF, when grafted to the VRA
lesion area [18]. No data, however, indicates that MC exhibit the
same properties.
Therefore, the present study investigated two delivery strategies
of MC, comparing the local injection to the spinal cord with the
possibility of mixing MC with fibrin sealant on the interface of the
CNS/PNS. Local production of BDNF and GDNF were
evaluated in both situations.
The results herein demonstrate that MC therapy is neropro-
tective and increases the transcript and protein levels of BDNF and
GDNF in the lesioned spinal cord area. Moreover, the adminis-
tration method significantly influenced treatment outcome, so that
the use of fibrin sealant MC delivery approach gave the best and
more long lasting results.
Material and Methods
2.1- Experimental animals
Adult female Lewis (LEW/HsdUnib) rats, 7 weeks old, were
obtained from the Multidisciplinary Center for Biological Inves-
tigation (CEMIB/UNICAMP) and housed under a 12-hour light/
dark cycle with free access to food and water. The study was
approved by the Institutional Committee for Ethics in Animal
Experimentation (Committee for Ethics in Animal Use – Institute
of Biology - CEUA/IB/UNICAMP, proc. nu 2073-1). All
experiments were performed in accordance with the guidelines
of the Brazilian College for Animal Experimentation. The animals
were subjected to unilateral avulsion of the L4-L6 lumbar ventral
roots and divided into 4 groups: 1) VRA without reimplantation
(AV 1 week, n= 5; AV 4 weeks, n = 15 and AV 8 weeks, n = 10); 2)
VRA followed by lesioned roots reimplantation with fibrin sealant
(AV+S 1 week n= 5, AV+S 4 weeks, n = 15 and AV+S 8 weeks,
n = 10); 3) VRA followed by lesioned roots reimplantation with
fibrin sealant and MC homogenized to the sealant (AV+S+HC 1
week, n= 5, AV+S+HC 4 weeks, n = 15 and AV+S+HC 8 weeks,
n = 10) and 4) VRA followed by lesioned roots reimplantation with
fibrin sealant and injection of MC (AV+S+IC 4 weeks, n = 15 and
AV+S+IC 8 weeks, n = 10).
The peroneal functional index was calculated weekly up to 8
weeks after injury (n = 10 for each group). Animals were killed 1
week and 4 weeks after injury and their lumbar spinal cords were
processed for PCR (n= 5 for each group). The animals were killed
after 4 and 8 weeks after avulsion and the lumbar spinal cords
were processed for immunohistochemistry (n = 5 for each group)
and neuronal survival counting (n = 5 for each group). Each
animal’s unlesioned, contralateral spinal cord side, served as an
internal control.
2.2- Bone Marrow Mononuclear Cells Extraction
MC were extracted from transgenic Lewis rats (LEW-Tg EGFP
F455/Rrrc), with the EGFP (Enhanced green fluorescent protein)
gene under Ubiquitin C promoter control. The animals were
imported from Missouri University (EUA) and were provided by
Dr. Alfredo Miranda Go´es, Federal University of Minas Gerais –
UFMG, Brazil.
The EGFP rats were killed with lethal dose of halothane
(Tanohalo, Crista´lia Chemicals and Pharmaceuticals, Brazil), and
the femur and tibia were dissected out from the muscular and
connective tissue. The cells were isolated by density gradient
centrifugation using Histopaque 1077 following the separation of
mononuclear cells methods of Sigma-Aldrich nu 1119 protocol.
The cell suspension consists of heterogeneous cell populations
(13.2% CD11b, 1.52% CD3, 92.2% CD45, 20.8% CD34 of
CD45). After 2 washing steps, cells were immediately transplanted.
2.3- Ventral root avulsion (VRA)
The rats were anesthetized with 50 mg/Kg of Ketamine (Fort
Dodge) and 10 mg/Kg of xylasine (Ko¨ning) and subjected to
unilateral avulsion of the lumbar ventral roots as previously
described [19]. Right side avulsion was performed at the L4, L5
and L6 lumbar ventral root after laminectomy. A longitudinal
incision was made to open the dural sac, the denticulate ligament
was dissected and the ventral roots associated with the lumbar
intumescence could be identified and avulsed with fine forceps
(Nº 4). Finally, the musculature, fascia and skin were sutured in
layers. Chlorhydrate of tramadol was administrated by gavage
after the surgical procedures (20 mg/kg) and 2.5 mg/day soluble
in water during 5 days.
2.4- Reimplantation of the motor roots
In AV+S, AV+S+MC and AV+S+IC groups, the roots were
replaced at the exact point of detachment, on the ventral surface of
the lumbar spinal cord at the avulsion site with the aid of a snake
venom fibrin sealant [10]. The fibrin sealant was kindly provided
by CEVAP/UNESP and is under the scope of the Brazilian
Patents BR 10 2014 011432 7 and BR 10 2014 011436 0 [20–22].
The sealant used herein is composed of three separate solutions (1-
fibrinogen, 2-calcium chloride and 3-thrombin-like fraction).
During surgical repair of the avulsed roots, the first two
components were applied and the avulsed roots were returned
to their original sites. The third component was then added for
polymerization. The reimplanted roots were then gently pulled
from the spinal cord, and the stability of the fixation was observed
to evaluate the success of the repair.
2.5- Mononuclear cells transplantation
In group 3 (AV+S+HC), 36105 MCs were added to the fibrin
sealant in avulsed roots reimplantation at the moment of
implantation. In this case, the cells are grouped in the right
ventrolateral surface of the spinal cord (Figure 1 A and B). In
group 4, 36105 MCs were placed directly into the lateral funiculus
on the lesioned side (ipsilateral) in the segments L4–L6 of the
spinal cord with the aid of a thick capillary Pasteur pipette coupled
to a Hamilton syringe and then the avulsed roots were repaired
with sealant. In this group, the cells are at the site of injection
(Figure 1 C and D).
2.6- Specimen preparation
The animals were anaesthetized with an overdose of mixture of
xylasine and Ketamine, and the vascular system was transcardially
perfused with phosphate buffer 0.1 M (pH 7.4). For PCR, the rats
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were killed 1 and 4 weeks after VRA and their lumbar
intumescences were frozen in liquid nitrogen. For neuron survival
counting and immunohistochemistry the rats were killed 4 and 8
weeks after VRA and fixed by vascular perfusion of 10%
formaldehyde in phosphate buffer (pH 7.4). The lumbar intumes-
cence was dissected, post-fixed overnight and then washed in
phosphate buffer and stored overnight in sucrose 20% before
freezing. Transverse cryostat 12 mm thick sections of spinal cords
were obtained and transferred to gelatin-coated slides and dried at
room temperature for 30 min before being stored at 220uC.
2.7- Counting of motoneurons survival
Cell counts were performed on sections from the lumbar
enlargement. Transverse cryostat sections of the spinal cords were
stained for 3 min in aqueous 1% cresyl fast violet solution (Sigma-
Aldrich, USA). The sections were then washed in distilled water,
dehydrated and mounted with Entellan (Merck, USA). The
motoneurons were identified (based on their morphology, size, and
location in the dorsolateral lamina IX) and cells with a visible
nucleus and nucleolus were counted. The absolute number of
motoneurons on the lesioned and non-lesioned side of each section
was used to calculate the percentage of surviving cells in each
specimen. This percentage was calculated by dividing the number
of motoneurons in the ipsilateral (lesioned) side by the number of
neurons in the contralateral (non-lesioned) side and multiplying
the result by 100. Abercrombie’s formula was used to correct for
the duplicate counting of neurons [23].
N~nt= tzdð Þ
where N is the corrected number of counted neurons, n is the
counted number of cells, t is the thickness of the sections (12 mm)
and d is the average diameter of the cells. Because differences in
cell size can significantly affect cell counts, the value of d was
calculated specifically for each experimental group and for both
ipsilateral and contralateral neurons. The diameters of 15
Figure 1. Scheme of the spinal cord subjected to motor root avulsion and reimplantation, with the two different cell delivery
locations. A) Scheme of transverse spinal cord section subjected to motor avulsion followed by fibrin sealant reimplantation plus MC. B) MC are
grouped in the right ventrolateral surface of the spinal cord (AV+S+HC), four weeks post surgery (4 w.p.s.). C) Scheme of the transverse spinal cord
section subjected to motor root avulsion followed by fibrin sealant reimplantation and cell injection in the lateral funiculus. D) The cells are at the site
of injection (AV+S+IC), 4 w.p.s. Such cells were E-GFP fluorescent donors. Scale bar = 50 mm.
doi:10.1371/journal.pone.0105712.g001
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randomly chosen neurons from each group were measured by
using the ImageTool software (version 3.00, The University of
Texas Health Science Center, San Antonio, USA).
2.8- Immunohistochemistry
Transverse sections of spinal cord were incubated with mouse
anti-synaptophysin (Dako, 1:250), goat anti-GFAP (Dako, 1:900),
and rabbit anti-Iba1 (Wako, 1:800) diluted in a solution containing
1% BSA in TBS-T (Tris-Buffered Saline and Tween) and 2%
Triton X-100 in PB 0.1 M (phosphate buffer). All sections were
incubated for 6 hours at room temperature in a moist chamber.
After rinsing in TBS-T, the sections were incubated according to
the primary host antibody (CY-3, Jackson Immunoresearch;
1:250) for 45 minutes in a moist chamber at room temperature.
After 3 times washing in TBS-T, the slides were mounted in a
mixture of glycerol/PBS (3:1) and observed with a Nikon eclipse
TS100 inverted microscope (Nikon, Japan). For quantitative
measurements, 3 representative images (with 2 MNs) of the spinal
cord (L4–L6 at lamina IX, ventral horn) from each animal were
captured at a final magnification of 6200. Double blind
quantification was performed in IMAGEJ software (version
1.33 u, National Institute of Health, USA) using the enhanced
contrast and density slicing two features [24]. The integrated
density of pixels was systematically measured in six representative
areas of the motor nucleus from each section, according to [19].
The integrated pixel density was calculated for each section of
spinal cord, and then a mean value for each spinal cord was
calculated. The data are represented as the mean6 standard error
(SE).
2.9- Real time polymerase chain reaction (PCR)
Total RNA was extracted from the ipsilateral and contralateral
sides of the frozen lumbar intumescences, 1 and 4 weeks after
lesion, using the RNeasy Lipid Tissue Kit (cat nu 74804, Quiagen),
according to the manufacturer’s recommendations. The RNA was
quantified using a NanoDrop Spectrophotometer (A260/280;
model 2000, Thermo Scientific). The RNA (1 mg) obtained from
five samples was reverse-transcribed using a commercial kit
(AffinityScripts QPCR cDNA Synthesis Kit - Agilent Technolo-
gies, La Jolla, CA, USA) to achieve a final reaction volume of
20 mL. Real time quantitative PCR was performed on Mx3005P
qPCR System (Agilent Technologies, La Jolla, CA, USA), after an
initial denaturation for 10 minutes at 95uC, followed by 35 cycles
of amplification (95uC for 30 seconds followed by 72uC for one
minute). The reactions were carried out with 12.5 mL 26SYBR
Green PCR master mix (Agilent Technologies), 0.2 mM of each
forward and reverse primer 100 ng cDNA template, in a final
reaction volume of 20 mL. All quantifications were normalized to
the house keeping gene b-actin. A non-template control with non-
genetic material was included to eliminate contamination or
nonspecific reactions. Each sample (n = 5) was tested in triplicate
and then used for the analysis of the relative transcription data
using the 22DDCT method [25]. The following forward (F) and
reverse (R) primers were used: BDNF: (F) 59-CCACAATGTTC-
CACCAGGTG-39, (R) 59-TGGGCGCAGCCTTCAT-39;
GDNF: (F) 59-CCACCATCAAAAGACTGAAAAG-39, (R) 59-
CGGTTCCTCTCTCTTCGAGGA-39; Iba-1 (F) 59- CCC-
CACCTAAGGCCACCAGC-39, (R) 59-TCCTGTTGGCTTT-
CAGCAGTCC-39; GFAP (F) 59-TGCTGGAGGGCGAA-
GAAAACCG-39 59-CCAGGCTGGTTTCTCGGATCTGG-39;
b-actin (F) 59-GGAGATTACTGCCCTGGCTCCTA-39 (R) 59-
GACTCAICGTACTCCTGCTTGCTG-39. The BDNF and
GDNF were based on [18] and the b-actin was based on [26].
2.10- Functional Analysis
For the gait recovery analysis, the CatWalk system (Noldus Inc.,
The Netherlands; was used. In this set up, the animal crosses a
walkway with an illuminated glass floor. A high-speed video
camera Gevicam (GP-3360, USA) equipped with a wide-angle lens
(8.5 mm, Fujicon Corp., China) is positioned underneath the
walkway and the paw prints are automatically recorded and
classified by the software. The paw prints from each animal were
obtained before and after the VRA. Post-operative CatWalk data
were collected twice a week for 12 weeks. The peroneal functional
index (PFI) was calculated as the distance between the third toe
and hind limb pads (print length) and the distance between the first
and fifth toes (print width). Measurements of these parameters
were obtained from the right (lesioned) and left (unlesioned) paw
prints, and the values were calculated using the following formula
[27].
PFI~174:9 x EPL{NPLð Þ=NPLð Þ)
z80:3x ETS{NTSð Þ=NTSð Þ){13:4
Where N: normal, or non-operated side; E: experimental, or
operated; PL: print length; TS: total toe spread, or distance
between first to fifth toe.
The pressure exerted on the platform by individual paws was
also evaluated. The Catwalk data from each day were expressed as
an ipsi-/contralateral ratio.
2.11- Statistical analysis
Statistical analysis was performed with Graphpad Prisma 4.0
software. The neuronal survival, immunohistochemistry, and PCR
were firstly evaluated with one-way ANOVA. Data from the
functional analysis was evaluated with two-way ANOVA.
Bonferroni post-test was used to identify intergroup differences.
The data are presented as the mean 6 SE and the differences
between groups were considered significant when the P-value was
,0.05 (*), ,0.01 (**) and ,0.001 (***).
Results
3.1- Neuroprotection after root reimplantation plus MC
treatment after VRA
Neuronal survival was assessed as the ipsi-/contralateral ratio of
motoneurons present in the lamina IX of the ventral horn. No
significant differences between the numbers of motoneurons on
the contralateral side in the different experimental conditions were
observed. After four weeks, there was severe degeneration of
affected motorneurons in the AV group (Fig. 2A). In implanted
groups (Fig 2 C, E and G) a higher number of surviving neurons
was observed. Such neuroprotection was even more evident in the
AV+S+HC group (Fig. 2I) (AV 36.09%63.67%; AV+S
65.19%66.93%; AV+S+HC 89.44%61.89%; AV+S+IC
64.60%61.33% percentage of survival ipsi-/contralateral 6
SEM; p,0.001).
Neuroprotection in the implanted groups remained superior to
the avulsion only throughout the time course of the study, i.e. up to
8 weeks post lesion (Fig. 2 D, E and F). Nevertheless, the AV+S+
HC group was similar to AV+S. Figure 2I shows the ipsi-/
contralateral ratio for the groups where a statistically significant
neuroprotective effect was observed (AV 34.58%64.12%; AV+S
66.46%63.88%; AV+S+HC 67.11%64.83%; AV+S+IC
46.81%65.87% percentage of survival ipsi-/contralateral 6
SEM; p,0.001).
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3.2- Decreased synaptic elimination after VRA followed
by implantation and cell treatment
Synaptic network changes after root avulsion were evaluated in
the ventral horn by immunohistochemistry with an antibody
against synaptophysin. Quantitative measurements of synaptophy-
sin immunoreactivity in the sciatic motor nuclei after avulsion
(AV) and after avulsion followed by ventral root implantation
(AV+S), implantation with cells homogenized on the sealant (AV+
S+HC) and implantation with cell injection (AV+S+IC) were
carried out. As shown in Fig. 3, AV only led to a significant
decrease in synaptophysin expression four weeks after avulsion,
which remained until 8 weeks. Such results indicate a significant
decrease of complexity of intraspinal networks following lesion. In
contrast, in implanted groups with or without cells, the repair
resulted in preservation of synaptophysin immunoreactivity, in the
immediate vicinity of the motoneurons. In AV+S+IC group the
synaptic inputs decreased when comparing 4 and 8 weeks. Four
weeks after avulsion: (AV 0.4360.01; AV+S 0.6660.09; AV+S+
HC 0.6560.07; AV+S+IC 0.6060.01 mean ratio ipsi-/contralat-
eral 6 SE with p,0.01) and 8 weeks after avulsion: (AV
0.4060.05; AV+S 0.7260.05; AV+S+HC 0.8460.07; AV+S+IC
0.85560.03 mean ratio ipsi-/contralateral 6 SE, p,0.05).
3.3- Astroglial reactivity is not further enhanced by
mononuclear cells around motoneuron vicinity
Immunoreactivity against GFAP was used to analyze the degree
of astroglial reactivity after lesion. This demonstrates the presence
of GFAP-positive astrocytic processes in the vicinity of the avulsed
motoneurons. Figure 4 shows that the astroglial reactivity was not
significantly further increased after implantation and cell treat-
ment in both experimental times: Four weeks after avulsion (AV
2.6560.48; AV+S 2.4960.60; AV+S+HC 2.6260.43; AV+S+IC
2.1760.12 mean ratio ipsi-/contralateral 6 SE); eight weeks after
avulsion (AV 3.4560.61; AV+S 2.0960.26; AV+S+HC
2.5860.37; AV+S+IC 2.3060.32 mean ratio ipsi-/contralateral
6 SE).
The real-time PCR analysis was performed to measure
GFAPmRNA in the RNA in all ventral horn after avulsion.
Figure 4 demonstrated that the levels of GFAPmRNA were
similar in all groups, 1 week (Fig 4 J) after lesion (AV 1.5160.38;
AV+S 1.2060.24; AV+S+HC 1.6560.26 mean ratio ipsi-/
contralateral 6 SE). However, 4 weeks (Fig 4 K) after avulsion,
AV+S group presented a decreased number of transcripts to
GFAP (AV 2.6460.45; AV+S 1.3560.14; AV+S+HC 2.1160.12;
AV+S+IC 2.0060.12 mean ratio ipsi-/contralateral 6 SE).
3.4- Microglial reactivity is enhanced by mononuclear
cells one week after tranplantation
To detect possible changes in the microglial cells close to large
motoneurons cell bodies after avulsion, the immunoreactivity
against Iba-1 was evaluated in the ventral horn in the different
experimental groups. Figure 5 shows that the microglial reactivity
was not significantly further increased after implantation and cell
treatment in both experimental times. However, the AV+S and
AV+S+IC groups showed decreased microglia reaction in the
course of experimental time. Four weeks after avulsion: (AV
4.7160.41; AV+S 4.7360.94; AV+S+HC 3.0260.64; AV+S+IC
5.6761.34; mean ratio ipsi-/contralateral 6SE with p,0.01) and
8 weeks after avulsion: (AV 2.7060.51; AV+S 2.1860.57; AV+S+
HC 2.3260.59; AV+S+IC 2.2560.35 mean ratio ipsi-/contralat-
eral 6 SE, p,0.05).
The real-time PCR analysis was performed to measure Iba-1
mRNA in the in ventral horn RNA after avulsion. Figure 5
demonstrated that the levels of Iba-1 mRNA in AV+S+HC were
significantly greater than in the AV and AV+S groups (AV
0.9560.30; AV+S 1.6360.60; AV+S+HC 4.1560.48 mean ratio
ipsi-/contralateral 6 SE). Nevertheless, 4 weeks (Fig 5 K) after
avulsion, Iba-1 mRNA were similar in all groups (AV 2.0760.26;
AV+S 1.0760.18; AV+S+HC 1.6460.26; AV+S+IC 1.7360.03
mean ratio ipsi-/contralateral 6 SE).
3.5- Mononuclear cells enhance BDNF and GDNF
expression one week after avulsion
Real time PCR was used to detect BDNF and GDNF mRNAs
in the lumbar spinal cord after avulsion (Figure 6). The results
demonstrated the levels of both neurotrophic factors in the AV+S+
HC group were significantly greater, when compared to the other
groups, one week after surgery (A and C) (BDNF - AV 1.2060.29;
AV+S 1.3360.18; AV+S+HC 2.4860.10 mean ratio ipsi-/
contralateral 6 SE *p,0.05) and (GDNF - AV 1.7160.56;
AV+S 1.2460.23; AV+S+HC 2.8660.34; mean ratio ipsi-/
contralateral 6 SE *p,0.05). Four weeks after avulsion, BDNF
and GDNF mRNA levels were similar in all groups (B and D)
(BDNF - AV 2.0460.18; AV+S 1.4560.35; AV+S+HC
1.5360.16; AV+S+IC 1.7060.17 mean ratio ipsi-/contralateral
6 SE) and (GDNF - AV 2.2560.10; AV+S 1.9260.43; AV+S+
HC 1.7260.30; AV+S+IC 1.7760.01 mean ratio ipsi-/contralat-
eral 6 SE).
3.6- Functional motor recovery
The recovery of motor function was analysed by the CatWalk
System. Post-operative assessments of peroneal function were
performed for eight consecutive weeks. The preoperative peroneal
functional index mean values (Figure 7A) did not significantly
differ between groups. The peroneal functional index drastically
declined after avulsion. The three implanted groups presented
significantly better peroneal index performance as compared to
AV group (AV 2228.89623.0; AV+S 2139.75612.5; AV+S+
HC 2155.50617.2; AV+S+IC 2205.14618.6, mean ratio ipsi-/
contralateral 6 SE, *p,0.05, **p,0.01 and ***p,0.001. These
results are consistent with the footprint paw pressure data
(Figure 7B), indicating that all three implanted groups presented
a better performance as compared to avulsion group (AV
0.2060.07; AV+S 0.8160.09726454; AV+S+HC 0.6660.078;
AV+S+IC 0.4060.11 mean ratio ipsi-/contralateral 6 SE with
*p,0.05 and ***p,0.001).
Figure 2. Nissl-stained spinal cord transverse sections at lamina IX illustrating the neuroprotective effects of root reimplantation
and MC treatment on motoneurons 4 and 8 weeks after VRA. Motoneuron cell bodies of the ipsilateral side of VRA after 4 weeks (A, C, E and
G) and after 8 weeks (B, D, F and H). (A and B) AV, (C and D) AV+S, (E and F) AV+S+HC and (G and H) AV+S+IC. Scale bar = 50 mm. (I) Percentage of
neuronal survival after ventral root avulsion, reimplantation and reimplantantion with MC. Note a significant rescue of lesioned neurons in the
implanted groups with and without cells in two different survival times (4 and 8 weeks). This neuroprotection was even more intense in AV+S+HC 4
weeks after avulsion. ({{ p,0.01 and {{{ p,0.001 comparing all groups 4 weeks after avulsion, 1 p,0.05, 11 p,0.01 and 111 p,0.001 comparing all
groups 8 weeks after AV and *p,0.05 comparing AV+S+HC at two different times after avulsion, n = 5).
doi:10.1371/journal.pone.0105712.g002
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Figure 3. Immunohistochemical analysis of the spinal cord ventral horn stained with anti-synaptophysin 4 and 8 weeks after VRA.
Observe the preservation of synaptophysin labeling, especially at the surface of the lesioned motoneurons in implanted group and both implanted
with mononuclear cells treatment. After 4 weeks post lesion (A, C, E and G) and after 8 weeks (B, D, F and H). (A and B) AV, (C and D) AV+S, (E and F)
AV+S+HC and (G and H) AV+S+IC. Scale bar = 50 mm. (I) Quantification of synaptic covering obtained by the ratio ipsi/contralateral sides of the
integrated density of pixels at lamina IX four and eight weeks after injury. ({{ p,0.01 comparing all groups 4 weeks after avulsion, 1 p,0.05
comparing all groups 8 weeks after AV and * p,0.05 comparing AV+S+IC at two different times after avulsion, n = 5).
doi:10.1371/journal.pone.0105712.g003
Figure 4. Glial fibrillary acidic protein (GFAP) in the spinal cord ventral horn. Immunohistochemical analysis of the anterior horn of the
spinal cord was labeled with anti-GFAP, 4 and 8 weeks after injury to assess the degree of astroglial reactivity after root avulsion (A–H). Representative
images of AV, AV+S, AV+S+HC and AV+S+IC. Scale bar = 50 mm. Observe that ventral root implantation and cell treatment did not increase astroglial
reaction. (I) The mean ratio of the ipsi-/contralateral integrated intensity of pixels of the ipsilateral and contralateral sides in all groups. (* p,0.05,
n = 5). (J) One week after avulsion, there were no differences between groups by GFAPmRNA analysis. (K) The RT-qPCR performed 4 weeks after
avulsion demonstrated significant decrease in the synthesis of GFAP mRNA in AV+S group compared with AV (*p,0.05, n = 5).
doi:10.1371/journal.pone.0105712.g004
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Discussion
Brachial plexus lesions are particularly debilitating and usually
affect young adults. To date, new technological refinements
aiming at improving the repair of such traumatic injury are
necessary. Although nerve reimplantation has been proposed
[7,10] the relatively poor clinical outcome requires further
attention. Treatment with neurotrophic factors, following root
reimplantation, has proven to be efficient [17]. Importantly, it has
been previously shown that mesenchymal stem cells naturally
produce BDNF and GDNF when grafted to the VRA lesion area
[18]. Considering it, the present study main objective was to
compare the root reimplantation regenerative outcome by either
injecting or engrafting the mononuclear cells at the wounded area,
Figure 5. Microglial analysis of the spinal cord ventral horn 4 and 8 weeks after VRA. The quantification analysis on motoneuron cell
bodies stained with anti- Iba1 of the ipsilateral side of VRA after 4 weeks (A, C, E and G) and after 8 weeks (B, D, F and H). (A and B) AV, (C and D) AV+S,
(E and F) AV+S+HC and (G and H) AV+S+IC. Scale bar = 50 mm. (I) The mean ratio of the ipsil-/contralateral integrated intensity of pixels of the
ipsilateral and contralateral sides in both groups. Note the decrease in microglial reactivity in AV+S and AV+S+IC as compared 4 and 8 weeks after
injury. (J) There were significant increase in the synthesis of Iba-1 mRNA in the lumbar spinal cord one week after avulsion (*p,0.05 and **p,0.01,
n = 5). (K) The RT-qPCR, performed 4 weeks after avulsion, did not demonstrate significant differences between groups in Iba-1 mRNA.
doi:10.1371/journal.pone.0105712.g005
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with aid of a fibrin sealant scaffold. However, evaluating the
perspective of translational studies, the use of bone marrow MC
has been preferred instead of mesenchymal stem cells.
The use of MC resulted in neuroprotection following peripheral
nervous system lesion [1,3] and following spinal cord injury [28].
Furthermore, the mononuclear fraction is easy to obtain,
implicating in lower costs and less processing time, as compared
with other cell types [1,29].
An important point to be observed is the best moment for
performing the cell therapy. Therefore, in some instances, it has
been proposed a late cell transplantation, following the acute
phase after injury [30]. However, immediate cell engrafting
increases the survival of motoneurons after root avulsion [17].
Based on such observations, the present work was based on cells
treatment immediately after avulsion, in order to obtain the best
neuroprotective results possible. This is particularly important
following CNS/PNS injuries that cause extensive degeneration of
adult motoneurons [31–33]. Such neuronal loss reaches up to 80%
of motoneuron degeneration in the first two weeks post injury [7].
Our results showed that both intraspinal administration and fibrin
sealant implantation of MC preserved a significant number of
motoneurons when compared to the untreated group (avulsion).
The neuroprotective effect observed herein reinforces that the
combination of root reimplantatio and cell therapy leads to
enhancement of axotomized motoneurons. On the contrary, most
of the motoneurons degenerated following AV, which reinforces
the need of acute neuroprotective treatments following VRA.
Neuronal rescue was highest following root reimplantation and
fibrin sealant cell engrafting, 4 weeks after injury. Such effect may
be the result of stem cell neurotrophic factor release in the site of
Figure 6. Neurotrophic factor expression (BDNF and GDNF) by RT-qPCR in the ventral horn spinal cord 1 and 4 weeks after
avulsion. Expression of mean ratio of the ipsi-/contralateral mRNA for BDNF obtained by RT-qPCR in the lumbar spinal cord one (A) and four (B)
weeks after avulsion. Note that one week after avulsion AV+S+HC enhanced the BDNF mRNA production compared to others groups (*p,0.05, n = 5).
Expression of mean ratio of the ipsi-/contralateral mRNA for GDNF obtained by RT-qPCR in the lumbar spinal cord one (C) and four (D) weeks after
avulsion. Note that, one week after avulsion in the AV+S+HC group, there is enhanced GDNF mRNA production as compared to others groups (*p,
0.05, n = 5).
doi:10.1371/journal.pone.0105712.g006
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Figure 7. Motor function recovery after ventral root treatment. (A) Graph of the peroneal nerve functional index up to 8 weeks after avulsion.
There is a significantly better performance of the three implanted groups compared to AV from the first week post lesion until the eighth week
(***p,0.001, **p,0.01 and *p,0.05 n = 10). (B) Restoration of weight-bearing capacity following avulsion. There is also a restoration of weight-
bearing capacity following avulsion in implanted groups with or without cells from the first up to the eight week after injury. Values are expressed as
the ratio of ipsi-/contralateral pressure exerted by the paw on the catwalk platform (***p,0.001 and *p,0.05, n = 10).
doi:10.1371/journal.pone.0105712.g007
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injury [17,18]. Nevertheless, the production of extracellular matrix
molecules has also been suggested as neuroprotective [34].
Neuronal survival decreased at 8 weeks post injury, indicating
that the therapeutic window for MC is relatively short and further
cell treatments may be necessary to maintain the axotomized
neurons.
Cell injection to the spinal cord gave similar results to the
reimplantation alone, 4 weeks post injury. However, neuronal
degeneration increased up to 8 weeks, reaching the level of
avulsion only. We believe that the injection into the CNS/PNS
interface result in a late inflammatory response that cause delayed
cell death. In this sense, using a similar reimplantation approach,
followed by mesenchymal stem cell injection, neuron preservation
has been shown without significant functional recovery [35].
Overall, the neuronal survival results indicate that fibrin sealant
homogenized MC result in acutely better results as compared to
intraspinal engrafting.
According to prior studies, MC express BDNF and GDNF [3]
in the PNS following sciatic nerve injury. BDNF is also produced
by MCs in the CNS, 3 and 7 days after MC therapy [4]. In line
with this, several studies have demonstrated neuroprotective effects
of such neurotrophic factors [7,32,36], especially after spinal cord
injury [37]. Neuroprotection is also achieved in neonatal animals
[38], where the effects of axotomy are more drastic than in adults.
The results herein are in line with the literature and show BDNF
and GDNF production by the MC, 1 week post injury.
Interestingly, BDNF, which is exacerbated in the implant group,
promotes axonal sprouting and elongation after peripheral nerve
injury and during development [39]. This is in line with the motor
recovery observed in all root reimplanted groups, suggesting
regeneration of axons after avulsion.
Functional analysis of the peroneal nerve, as well as the pressure
exerted by the ipsilateral paw, provides reliable data on functional
recovery of animals with motor problems [40,41]. The motor
improvement observed herein is noteworthy because gait restora-
tion is necessarily related to motor units recovery, together with
cerebral cortex control [42]. Importantly, the preservation of pre-
synaptic inputs to the injured motoneurons after implantation,
observed by immunohistochemistry, indicates preservation of
supraspinal contacts.
An important occurrence following VRA is the reduction of
pre-synaptic terminals to motoneurons [42,43]. This synaptic
decrease become irreversible if the regrowing axons within the
root do not reach their target muscles [43]. Importantly, the
groups subjected to root reimplantation showed a significant
preservation of synapses as compared to the avulsion only group.
In this case, cell treatment gave no further benefit, indicating that
the restoration of CNS/PNS connection is sufficient to preserve
spinal synaptic networks. Coupled with such synaptic changes,
glial cells became reactive following VRA. Such reactive gliosis is
characterized by hypertrophy of the cell body and processes of
astrocytes and microglial hyperplasia [44–46].
Although the microglial reaction was morphologically decreased
by MC treatment four weeks post lesion, at one week, an
enhancement of Iba-1 gene transcripts was obtained. One
possibility is that MCs increased or accelerated acute microglial
response [47]. Regarding the astrogliosis, no differences were
perceived between groups by immunohistochemical analysis.
qPCR data, on the other hand, indicated a decreased number of
GFAP gene transcripts following root reimplantation alone. This is
in line with what has been observed 12 weeks after root
reimplantation [10].
Conclusions
Taken together, the results of the present study indicate that
MCs therapy further preserves injured motoneurons up to 4 weeks
after implantation, in comparison to root reimplantation alone.
Such fact is possibly related to the production of neurotrophic
factors, such as BDNF and GDNF. Nonetheless, such difference
was not seen at 4 weeks post injury. This may in turn indicate that
restoration of the CNS/PNS connection must be carried out in a
short period of time after avulsion. Importantly, the present data
indicate that cell injection to the spinal cord does not result in long
lasting neuroprotection. On the other hand, engrafting of MC at
the site of injury with the aid of a fibrin scaffold is effective and
may represent a more practical approach, with regard to
translational medicine.
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